Anesthetic and cardiopulmonary effects of intramuscular morphine, medetomidine, ketamine injection in dogs

Veterinary Anaesthesia and Analgesia

Volumn 35, Issue 6, 2008, Pages 480-487

  Ueyema, Yukie ^a   Waselau, Anja Christina ^a   Wiese, Ashley J ^a   Muir, William W ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b Veterinary Clinical Pharmacology Consulting Services   (United States)

Author keywords

Atipamezole; Injectable anesthesia; Ketamine; Medetomidine; Morphine

Indexed keywords

ANIMALIA; CANIS FAMILIARIS;

EID: 54049086092     PISSN: 14672987     EISSN: 14672995     Source Type: Journal    
DOI: 10.1111/j.1467-2995.2008.00415.x     Document Type: Article

References (29)

1. Critchley LA, Peng ZY, Fok BS et al. (2005) Testing the reliability of a new ultrasonic cardiac output monitor, the USCOM, by using aortic flowprobes in anesthetized dogs. Anesth Analg 100, 748 753.
2. Glowaski MM, Wetmore LA (1999) Propofol: application in veterinary sedation and anesthesia. Clin Tech Small Anim Pract 14, 1 9.
3. Haskins S, Farver T, Patz J (1985) Ketamine in dogs. Am J Vet Res 46, 1855 1860.
4. Hayashi K, Nishimura R, Yamaki A et al. (1994) Comparison of sedative effects induced by medetomidine, medetomidine-midazolam and medetomidine- butorphanol in dogs. J Vet Med Sci 56, 951 956.
5. Hubbell JAE (1994) Compounding in veterinary anesthesiology. J Am Vet Med Assoc 205, 202 204.
6. Ilkiw JE (1999) Balanced anesthetic techniques in dogs and cats. Clin Tech Small Anim Pract 14, 27 37.
7. Jalanka H, Skutnabb K, Damsten Y (1989) Preliminary results on the use of medetomidine-ketamine combinations in the dog. Acta Vet Scand Suppl 85, 125 127.
8. Ko JCH, Bailey JE, Pablo LS et al. (1996) Comparison of sedative and cardiorespiratory effects of medetomidine and a medetomidine-butorphanol combination in dogs. Am J Vet Res 57, 535 540.
9. Ko JCH, Fox SM, Mandsager RE (2000) Sedative and cardiorespiratory effects of medetomidine, medetomidine-butorphanol, and medetomidine-ketamine in dogs. J Am Vet Med Assoc 216, 1578 1583.
10. Kuo WC, Keegan RD (2004) Comparative cardiovascular, analgesic, and sedative effects of medetomidine, medetomidine-hydromorphone, and medetomidine-butorphanol in dogs. Am J Vet Res 65, 931 937.
11. Lamont L, Tranquilli W (2002) α2-agonisits. In : Handbook of Veterinary Pain Management. Gaynor JS, Muir WW (ed). Mosby, St Louis, MO. pp. 199 220.
12. Lerche P, Muir WW III. (2004) Effect of medetomidine on breathing and inspiratory neuromuscular drive in conscious dogs. Am J Vet Res 65, 720 724.
13. Moens Y, Fargetton X (1990) A comparative study of medetomidine/ketamine and xylazine/ketamine anaesthesia in dogs. Vet Rec 127, 567 571.
14. de Morais HS, Muir WW III. (1995) The effect of medetomidine on cardiac contractility in autonomically blocked dogs. Vet Surg 24, 356 364.
15. Muir WW, Pipers FS (1977) The effect of xylazine on indices of myocardial contractility in the dog. Am J Vet Res 38, 931 934.
16. Muir WW III., Ford JL, Karpa GE et al. (1999) Effects of intramuscular administration of low doses of medetomidine and medetomidine-butorphanol in middle-aged and old dogs. J Am Vet Med Assoc 215, 1116 1120.
17. Muir WW III., Hubbell JAE, Bednarski RM et al. (2007a) Patient evaluation and preparation. In : Handbook of Veterinary Anesthesia (4th edn). Muir WW, Hubbell JAE, Bednarski RM, Skarda RT (ed). Mosby, St Louis, MO. pp. 14 21.
18. Muir WW III., Hubbell JAE, Bednarski RM et al. (2007b) Drugs used for preanesthetic medication. In : Handbook of Veterinary Anesthesia (4th edn). Muir WW, Hubbell JAE, Bednarski RM, Skarda RT (ed). Mosby, St Louis, MO. pp. 38 40.
19. Muir WW III., Hubbell JAE, Bednarski RM et al. (2007c) Specific intravenous anesthetic drugs. In : Handbook of Veterinary Anesthesia (4th edn). Muir WW, Hubbell JAE, Bednarski RM, Skarda RT (ed). Mosby, St Louis, MO, pp. 160 163.
20. Ossipov MH, Harris S, Lloyd P et al. (1990) Antinociceptive interaction between opioids and medetomidine: systemic additivity and spinal synergy. Anesthesiology 73, 1227 1235.
21. Pozzi A, Muir WW, Traverso F (2006) Prevention of central sensitization and pain by N-methyl-d-aspartate receptor antagonists. J Am Vet Med Assoc 228, 53 60.
22. Pypendop BH, Verstegen JP (1998) Hemodynamic effects of medetomidine in the dog: a dose titration study. Vet Surg 27, 612 622.
23. Robinson KJ, Jones RS, Cripps PJ (2001) Effects of medetomidine and buprenorphine administered for sedation in dogs. J Small Anim Pract 42, 444 447.
24. ® noninvasive cardiac output system. J Vet Intern Med 21, 635 (Abstract).
25. Serteyn D, Coppens P, Jones R et al. (1993) Circulatory and respiratory effects of the combination medetomidine-ketamine in beagles. J Vet Pharmacol Ther 16, 199 206.
26. Sinclair MD (2003) A review of the physiological effects of α2-agonisits related to the clinical use of medetomidine in small animal practice. Can Vet J 44, 885 897.
27. Tomizawa N, Tomita I, Nakamura K et al. (1997) A comparative study of medetomidine-butorphanol-ketamine and medetomidine-ketamine anaesthesia in dogs. Zentralbl Veterinarmed A 44, 189 194.
28. Virtanen R (1989) Pharmacological profiles of medetomidine and its antagonists, atipamezole. Acta Vet Scand Suppl 85, 29 37.
29. Wiese JA, Muir WW III. (2007) Anesthetic and cardiopulmonary effects of intramuscular morphine, medetomidine and ketamine administered to telemetered cats. J Feline Med Surg 9, 150 156.